575 related articles for article (PubMed ID: 29144805)
1. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
Ferjan S; Janez A; Jensterle M
Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
[TBL] [Abstract][Full Text] [Related]
2. SHORT-TERM SITAGLIPTIN-METFORMIN THERAPY IS MORE EFFECTIVE THAN METFORMIN OR PLACEBO IN PRIOR GESTATIONAL DIABETIC WOMEN WITH IMPAIRED GLUCOSE REGULATION.
Elkind-Hirsch KE; Paterson MS; Shaler D; Gutowski HC
Endocr Pract; 2018 Apr; 24(4):361-368. PubMed ID: 29561188
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
Ferjan S; Janez A; Jensterle M
Metab Syndr Relat Disord; 2017 Dec; 15(10):515-520. PubMed ID: 29064743
[TBL] [Abstract][Full Text] [Related]
4. Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved β-cell function and insulin sensitivity in metformin treated PCOS.
Jensterle M; Goricar K; Janez A
Endocr Res; 2017 Nov; 42(4):261-268. PubMed ID: 28323503
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome.
Devin JK; Nian H; Celedonio JE; Wright P; Brown NJ
J Clin Endocrinol Metab; 2020 Jan; 105(1):136-51. PubMed ID: 31529097
[TBL] [Abstract][Full Text] [Related]
6. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
[TBL] [Abstract][Full Text] [Related]
7. Effects of saxagliptin on glucose homeostasis and body composition of obese patients with newly diagnosed pre-diabetes.
Wang Z; Xu D; Huang L; Zhang T; Wang J; Chen Q; Kong L; Zhou X
Diabetes Res Clin Pract; 2017 Aug; 130():77-85. PubMed ID: 28575729
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
9. Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.
Kelly A; Sheikh S; Stefanovski D; Peleckis AJ; Nyirjesy SC; Eiel JN; Sidhaye A; Localio R; Gallop R; De Leon DD; Hadjiliadis D; Rubenstein RC; Rickels MR
J Clin Endocrinol Metab; 2021 Aug; 106(9):2617-2634. PubMed ID: 34406395
[TBL] [Abstract][Full Text] [Related]
10. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
Zhang J; Xing C; Cheng X; He B
Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
[TBL] [Abstract][Full Text] [Related]
11. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Ezeh U; Pall M; Mathur R; Azziz R
Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
[TBL] [Abstract][Full Text] [Related]
12. Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes.
Otsuka Y; Yamaguchi S; Furukawa A; Kosuda M; Nakazaki M; Ishihara H
Endocr J; 2015; 62(2):133-43. PubMed ID: 25328079
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
15. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Lin XF; Wu RR; Du J; Liao YC; Du Y; Ye Y; Wang Y; Zhang XB; Wu C; Chen A
Clin Exp Obstet Gynecol; 2015; 42(3):315-20. PubMed ID: 26152001
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.
Li J; Ng EH; Stener-Victorin E; Hu Z; Shao X; Wang H; Li M; Lai M; Xie C; Su N; Yu C; Liu J; Wu T; Ma H
Trials; 2017 Mar; 18(1):115. PubMed ID: 28274268
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
19. Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome.
Ou HT; Chen PC; Wu MH
J Formos Med Assoc; 2017 Feb; 116(2):80-89. PubMed ID: 27131512
[TBL] [Abstract][Full Text] [Related]
20. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.
Tao T; Wu P; Wang Y; Liu W
BMC Endocr Disord; 2018 Feb; 18(1):14. PubMed ID: 29482528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
